PBM Tailwinds in the New Millennium: Specialty Drugs, Specialty Pharmacies, and Insurance Expansion

Lawton Robert Burns () and Adam Fein ()
Additional contact information
Lawton Robert Burns: The Wharton School, University of Pennsylvania

Chapter Chapter 11 in The Healthcare Value Chain, 2022, pp 491-530 from Springer

Abstract: Abstract PBMs have undergone several significant changes since the start of the new millennium. First, PBMs benefitted from long-term underlying trends that fueled demand for pharmaceuticalsPharmaceuticals, including population aging and growing chronicity.

Date: 2022
References: Add references at CitEc
Citations:

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:sprchp:978-3-031-10739-9_11

Ordering information: This item can be ordered from
http://www.springer.com/9783031107399

DOI: 10.1007/978-3-031-10739-9_11

Access Statistics for this chapter

More chapters in Springer Books from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().